Stock Analysts

Medtronic Initiates Study on Absorbable Antibacterial Envelope

Medical device major, Medtronic, Inc. ( MDT ), recently reported the registration and surgical implant of the first patient in its global clinical study – WRAP Infection Clinical Trial. The primary aim of this trial is to estimate the efficiency of Medtronic's TYRX Absorbable Antibacterial Envelope in minimizing major infections in roughly 7,000 patients grafted with cardiac implantable electronic devices (CIEDs), who are at risk of infection […]

Stock Analysts

Valmont (VMI) Downgraded to Sell on Near-term Headwinds

On Jan 6, Zacks Investment Research downgraded Valmont Industries ( VMI ) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold). Why the Downgrade? While the steel pipe and tube company’s long-term prospects look healthy, it is faced with some near-term challenges in its utility and irrigation businesses […]

Stock Analysts

Matador Resources to Focus Only on Permian Basin in 2015

In its current operational update, upstream energy firm Matador Resources Company ( MTDR ) declared that it is planning to focus only on Permian Basin in 2015. Presently, the company is operating a total of five rigs in the Permian Basin and Eagle Ford shale. However, following a weak oil and natural gas pricing environment, Matador Resources will likely operate three new build rigs − capable of performing drilling and completion activities simultaneously – in the Permian Basin. […]

Stock Analysts

Should Xerox (XRX) Stock Be in Your Portfolio Now?

On Jan 7, Zacks Investment Research upgraded information technology services provider Xerox Corporation ( XRX ) to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell) largely on the back of healthy long-term fundamentals fuelled by the divesture of non-core assets and focus on inorganic growth. The stock is currently trading at a forward P/E of 12.1x and has long-term earnings growth expectation of 7.0%. Why the Upgrade? […]